STRS Ohio’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,462
| Closed | -$453K | – | 2164 |
|
|
2025
Q4 | $453K | Buy |
4,462
+8
| +0.2% | +$642 | ﹤0.01% | 1145 |
|
|
2025
Q3 | $244K | Buy |
4,454
+2
| +0% | +$100 | ﹤0.01% | 1443 |
|
|
2025
Q2 | $237K | Buy |
+4,452
| New | +$226K | ﹤0.01% | 1610 |
|
|
2024
Q2 | – | Sell |
-11,014
| Closed | -$760K | – | 2000 |
|
|
2024
Q1 | $760K | Sell |
11,014
-11,885
| -52% | -$752K | ﹤0.01% | 1014 |
|
|
2023
Q4 | $1.69M | Sell |
22,899
-383
| -2% | -$25.1K | 0.01% | 674 |
|
|
2023
Q3 | $1.59M | Buy |
23,282
+1,864
| +9% | +$158K | 0.01% | 702 |
|
|
2023
Q2 | $2.01M | Buy |
21,418
+9,418
| +78% | +$735K | 0.01% | 614 |
|
|
2023
Q1 | $813K | Hold |
12,000
| – | – | ﹤0.01% | 1032 |
|
|
2022
Q4 | $594K | Hold |
12,000
| – | – | ﹤0.01% | 1225 |
|
|
2022
Q3 | $389K | Hold |
12,000
| – | – | ﹤0.01% | 1415 |
|
|
2022
Q2 | $472K | Sell |
12,000
-1,805
| -13% | -$96.5K | ﹤0.01% | 1375 |
|
|
2022
Q1 | $965K | Hold |
13,805
| – | – | ﹤0.01% | 1064 |
|
|
2021
Q4 | $1.07M | Hold |
13,805
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q3 | $1.32M | Sell |
13,805
-6,213
| -31% | -$656K | 0.01% | 941 |
|
|
2021
Q2 | $2.49M | Buy |
20,018
+7,984
| +66% | +$953K | 0.01% | 667 |
|
|
2021
Q1 | $1.58M | Buy |
12,034
+2,872
| +31% | +$393K | 0.01% | 846 |
|
|
2020
Q4 | $1.21M | Sell |
9,162
-618
| -6% | -$74.7K | ﹤0.01% | 945 |
|
|
2020
Q3 | $997K | Buy |
+9,780
| New | +$845K | ﹤0.01% | 926 |
|
|
2019
Q4 | – | Sell |
-66,784
| Closed | -$6.04M | – | 2087 |
|
|
2019
Q3 | $6.04M | Buy |
66,784
+200
| +0.3% | +$22.8K | 0.03% | 426 |
|
|
2019
Q2 | $7.86M | Sell |
66,584
-266
| -0.4% | -$26.8K | 0.03% | 384 |
|
|
2019
Q1 | $5.79M | Buy |
66,850
+64,295
| +2,516% | +$5.47M | 0.03% | 426 |
|
|
2018
Q4 | $161K | Buy |
+2,555
| New | +$175K | ﹤0.01% | 1682 |
|
|
2018
Q3 | – | Sell |
-2,915
| Closed | -$174K | – | 2128 |
|
|
2018
Q2 | $174K | Sell |
2,915
-42,385
| -94% | -$2.28M | ﹤0.01% | 1781 |
|
|
2018
Q1 | $1.83M | Sell |
45,300
-200
| -0.4% | -$9.76K | 0.01% | 648 |
|
|
2017
Q4 | $2.39M | Sell |
45,500
-13,900
| -23% | -$742K | 0.01% | 595 |
|
|
2017
Q3 | $2.8M | Buy |
59,400
+38,300
| +182% | +$1.54M | 0.01% | 583 |
|
|
2017
Q2 | $746K | Sell |
21,100
-9,300
| -31% | -$287K | ﹤0.01% | 1025 |
|
|
2017
Q1 | $718K | Sell |
30,400
-109,500
| -78% | -$2.17M | ﹤0.01% | 1065 |
|
|
2016
Q4 | $1.87M | Sell |
139,900
-165,500
| -54% | -$2.67M | 0.01% | 646 |
|
|
2016
Q3 | $5.67M | Sell |
305,400
-344,600
| -53% | -$6.07M | 0.03% | 475 |
|
|
2016
Q2 | $7.96M | Buy |
650,000
+518,318
| +394% | +$3.9M | 0.04% | 410 |
|
|
2016
Q1 | $887K | Buy |
+131,682
| New | +$842K | ﹤0.01% | 858 |
|
|
2015
Q4 | – | Sell |
-2,200
| Closed | -$39K | – | 1926 |
|
|
2015
Q3 | $39K | Sell |
2,200
-6,000
| -73% | -$138K | ﹤0.01% | 1780 |
|
|
2015
Q2 | $243K | Sell |
8,200
-3,100
| -27% | -$77.9K | ﹤0.01% | 1517 |
|
|
2015
Q1 | $248K | Sell |
11,300
-300
| -3% | -$7.61K | ﹤0.01% | 1408 |
|
|
2014
Q4 | $318K | Buy |
11,600
+5,200
| +81% | +$127K | ﹤0.01% | 1328 |
|
|
2014
Q3 | $124K | Buy |
+6,400
| New | +$117K | ﹤0.01% | 1535 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
STRS Ohio's EXAS Position: Q1 2026 in Review
STRS Ohio sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,462 shares — an estimated $453K sold.
STRS Ohio first reported a position in EXAS in Q3 2014 and held it in 37 quarters. The position peaked at $7.96M in Q2 2016. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- STRS Ohio reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- STRS Ohio sold 4,462 Exact Sciences shares in Q1 2026, an estimated $453K.
- STRS Ohio first reported a position in Exact Sciences in Q3 2014 and held it in 37 quarters.
- STRS Ohio's Exact Sciences position peaked at $7.96M in Q2 2016.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.